Bridge launch rules to check before your first fill
Published by GLP-1 Coverage Guide · Updated · No clinician review is credited for this page.
Published 2026-07-21 · Updated 2026-10-05
Correction, October 5, 2026: the original article described launch performance and common problems without supporting outcome data. Those statements have been removed. The guidance below describes published program rules, not observed denial rates or patient experiences.
Check the pharmacy-first sequence and the exact formulation with your prescriber and pharmacy. An initial claim requesting PA is expected; other claim responses need their actual reason checked. Zepbound must be KwikPen, and CMS includes Wegovy injections and tablets.
The $50 applies to each authorized 28-day or 30-day fill and is outside Part D. Extra Help does not reduce it, and it does not count toward Part D out-of-pocket spending. Consult the application and pharmacy guides for the steps and direct CMS sources.
Check your eligibility in 2 minutes →
Sources: CMS covered formulations and process · CMS prior authorization form